about
Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages.Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patientsNLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritisEffects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese malesDEL-1 promotes macrophage efferocytosis and clearance of inflammationCausal relationships among the gut microbiome, short-chain fatty acids and metabolic diseasesGenetic variation in Interleukin-32 influence the immune response against New World Leishmania species and susceptibility to American Tegumentary LeishmaniasisRare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of goutAuthor Correction: Training the trainable cells of the immune system and beyondAsymptomatic hyperuricaemia: a silent activator of the innate immune systemPredicting bacterial infection outcomes using single cell RNA-sequencing analysis of human immune cellsUrate-induced immune programming: Consequences for gouty arthritis and hyperuricemiaAntibody neutralization of microbiota-derived circulating peptidoglycan dampens inflammation and ameliorates autoimmunityTraining the trainable cells of the immune system and beyondA joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritisTherapeutic targeting of trained immunityPhagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunityAcute Cytokine Response During Breast Cancer Surgery: Potential Role of Dexamethasone and Lidocaine and Relationship with Postoperative Pain and Complications - Analysis of Three Pooled Pilot Randomized Controlled Trials
P50
Q40357866-3F313A1B-F80D-44F4-926E-F540688BC79EQ58719858-FAEFE9C5-E0DA-43BA-881F-CBDFF24B2148Q58801340-788ECF97-1176-48AC-B0C4-384BCFA4A932Q61443425-621691FA-F55F-4887-8D4D-85FB3544ADA0Q63546850-C40D1243-5ECB-4AC2-A715-AAA5F8903F9AQ63916389-F6814098-71C1-4599-95E7-C12DE918044AQ89547378-CC49C198-3866-4E45-A815-A3591D3C0424Q89957499-17A3C661-EFD5-4E13-8706-4097D16A1F8EQ90246764-C678B35F-D101-4DA9-B3DC-B41D39B45D6AQ91855893-0EF73E44-8B47-4581-A4E8-C9B63FA6BD45Q92092328-47E74FAD-3347-46EA-9558-EDF950E8826EQ92106778-51456448-AF23-4F04-AAC8-FF212281647BQ92129002-F526B1B0-AC5C-461B-A191-8F2238B1E6E0Q92564884-C3A955BB-9173-43E1-AA0A-87CF24B4BD54Q92598688-113676CB-3C4D-42D2-9856-088BE2315BB8Q92987543-DE7DC130-629A-48BD-81AC-D35D5CEEC1E5Q94569365-7559FE1E-B3F2-4C94-84D3-3E9890F42EDFQ96433113-41F4194D-3028-4097-802D-F0D83BDC99E5
P50
description
researcher
@en
name
Leo A B Joosten
@en
type
label
Leo A B Joosten
@en
prefLabel
Leo A B Joosten
@en
P31
P496
0000-0001-6166-9830